What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations?-Reference-Cited by-同舟云学术

What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations?

Published:2019-11-25 Issue:1 Volume:20 Page:27-37
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

van Dongen Johanna M¹²,El Alili Mohamed¹,Varga Anita N¹,Guevara Morel Alejandra E¹,Jornada Ben Angela¹,Khorrami Mojdeh¹²,van Tulder Maurits W²³,Bosmans Judith E¹

Affiliation:

1. Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, Amsterdam, the Netherlands

2. Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, MOVE research institute Amsterdam, Amsterdam, the Netherlands

3. Department of Clinical Medicine - Department of Physiotherapy and Occupational Therapy, Aarhus University Hospital, Aarhus, Denmark

Funder

The study was internally funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1694410

Reference87 articles.

1. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting